When was Gencove founded?

Gencove was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Gencove located?

Gencove is headquartered in New York City, United States.

How many employees does Gencove have?

As of May 31, 2026, the latest employee count at Gencove is 15.

Is Gencove a funded company?

Gencove is a funded company, having raised a total of $16.2M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 11, 2017.

When was the latest funding round of Gencove?

Gencove's latest funding was a $***** Series A round on Oct 26, 2021, with participation from 5 investors.

Where does Gencove rank among its competitors?

Gencove ranks 48th amongst 775 active competitors, of which 95 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of Gencove?

Gencove's top competitors include Strand Life Sciences, Tessera Therapeutics and BGI. Among them, SeqOne secured the most recent funding round in May, 2025.

Gencove - 2026 Company Profile, Team, Funding & Competitors

Company Details

Gencove, formerly seeq.io, is a personal genomics service. The company's focus is centered around its app-based data reporting system. The client purchases a kit that is used to transport saliva to the company's labs, where it undergoes ultra-low coverage whole genome sequencing. The data is analyzed and shared with the client through the app, which allows the client to explore ancestry and information about the oral microbiome with friends easily. The client can also download the raw sequencing data for analysis at their end. The company also gives the clients, the possibility to participate in population genetics studies, in addition to designing and executing population genomics research programs for clients.

Website: gencove.com
Social
Email ID: *****@gencove.com

Key Metrics

Founded Year

2016

Location

New York City, United States

Stage

Series A

Total Funding

$16.2M in 5 rounds

Latest Funding Round

Series A, Oct 26, 2021, $*****

Investors

Spero Ventures & 11 more

Ranked

48^th among 775 active competitors

Employee Count

15 as on May 31, 2026

Similar Companies

Strand Life Sciences & 876 more

View Gencove's full profile

Gencove has raised a total funding of $16.2M over 5 rounds. Its first funding round was on Jul 11, 2017. Its latest funding round was a Series A round on Oct 26, 2021 for $*****. 5 investors participated in its latest round. Gencove has 12 institutional investors.

Here is the list of recent funding rounds of Gencove:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 26, 2021	8366421	Series A	6904578	8450254	4660472	6108073
Apr 19, 2021	1618400	Series A	5860932	5770547	1531941	8332624
May 01, 2019	3259029	Grant (prize money)	6749346	3735582	9085835	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Gencove's funding rounds and investors

The founders of Gencove are Kaja Wasik and Tomaz Berisa.

Here are the details of Gencove's key team members:

Kaja Wasik: Co-Founder of Gencove.
Contact Info: 1 email address
Tomaz Berisa: Co-Founder of Gencove.
Contact Info: 1 email address

View details of Gencove's Founder profiles and Board Members

Gencove's employee count trend

Gencove has 15 employees as of May 26. Here is Gencove's employee count trend over the years:

Uncover Gencove's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Gencove include Strand Life Sciences, Tessera Therapeutics and BGI. Here is the list of Top 10 competitors of Gencove, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	73/100
2nd	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	ADIA, Temasek & 22 others	64/100
3rd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	64/100
4th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
5th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	60/100
6th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	60/100
7th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	59/100
8th	Replay 2021, San Diego (United States), Acquired	Provider of genomic reprogramming platform for writing and delivering big DNA	$55M	OMX Ventures, KKR & 6 others	58/100
9th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Supernova Invest & 7 others	58/100
10th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
48th	Gencove 2016, New York City (United States), Series A	Cloud platform for personal genomics	$16.2M	Spero Ventures, Alexandria & 10 others	43/100